128 related articles for article (PubMed ID: 38277295)
21. Blood-brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease.
Bruno M; Bonomi CG; Ricci F; Di Donna MG; Mercuri NB; Koch G; Martorana A; Motta C
Eur J Neurol; 2024 Jan; 31(1):e16095. PubMed ID: 37823706
[TBL] [Abstract][Full Text] [Related]
22. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo.
Bai Y; Ma X
Int Immunopharmacol; 2020 Nov; 88():106790. PubMed ID: 32795892
[TBL] [Abstract][Full Text] [Related]
23. Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer's disease pathology.
Rosenberger AF; Morrema TH; Gerritsen WH; van Haastert ES; Snkhchyan H; Hilhorst R; Rozemuller AJ; Scheltens P; van der Vies SM; Hoozemans JJ
J Neuroinflammation; 2016 Jan; 13():4. PubMed ID: 26732432
[TBL] [Abstract][Full Text] [Related]
24. The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia.
Belkhelfa M; Beder N; Mouhoub D; Amri M; Hayet R; Tighilt N; Bakheti S; Laimouche S; Azzouz D; Belhadj R; Touil-Boukoffa C
J Neuroimmunol; 2018 Jul; 320():48-57. PubMed ID: 29759140
[TBL] [Abstract][Full Text] [Related]
25. Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration.
Matousek SB; Ghosh S; Shaftel SS; Kyrkanides S; Olschowka JA; O'Banion MK
J Neuroimmune Pharmacol; 2012 Mar; 7(1):156-64. PubMed ID: 22173340
[TBL] [Abstract][Full Text] [Related]
26. Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer's disease: the role of TNF-α/NF-κB/IL-1β axis inhibition.
Nafea M; Elharoun M; Abd-Alhaseeb MM; Helmy MW
Naunyn Schmiedebergs Arch Pharmacol; 2023 Mar; 396(3):485-498. PubMed ID: 36385687
[TBL] [Abstract][Full Text] [Related]
27. [Pathomorphological and amyloid beta-protein immunohistochemical findings in autopsied brains of Alzheimer's disease].
Liu D; Hk N; Man K; Luo X; Yang L; Sun Z
Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):405-8. PubMed ID: 11869551
[TBL] [Abstract][Full Text] [Related]
28. The Molecular Mechanisms of Neuroinflammation in Alzheimer's Disease, the Consequence of Neural Cell Death.
Choi SB; Kwon S; Kim JH; Ahn NH; Lee JH; Yang SH
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511515
[TBL] [Abstract][Full Text] [Related]
29. Roles of Cytokines in Alzheimer's Disease.
Chen Z; Balachandran YL; Chong WP; Chan KWY
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891990
[TBL] [Abstract][Full Text] [Related]
30. Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease.
Cabinio M; Saresella M; Piancone F; LaRosa F; Marventano I; Guerini FR; Nemni R; Baglio F; Clerici M
J Alzheimers Dis; 2018; 66(3):1131-1144. PubMed ID: 30400090
[TBL] [Abstract][Full Text] [Related]
31. DMTHB ameliorates memory impairment in Alzheimer's disease mice through regulation of neuroinflammation.
Zhang Y; Liu D; Yao X; Wen J; Wang Y; Zhang Y
Neurosci Lett; 2022 Aug; 785():136770. PubMed ID: 35810961
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.
Tweedie D; Ferguson RA; Fishman K; Frankola KA; Van Praag H; Holloway HW; Luo W; Li Y; Caracciolo L; Russo I; Barlati S; Ray B; Lahiri DK; Bosetti F; Greig NH; Rosi S
J Neuroinflammation; 2012 May; 9():106. PubMed ID: 22642825
[TBL] [Abstract][Full Text] [Related]
33. Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway.
Yang R; Liu S; Zhou J; Bu S; Zhang J
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):276-284. PubMed ID: 28669260
[TBL] [Abstract][Full Text] [Related]
34. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
[TBL] [Abstract][Full Text] [Related]
35. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
[TBL] [Abstract][Full Text] [Related]
36. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
37. Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain.
Grammas P; Ovase R
Am J Pathol; 2002 May; 160(5):1583-7. PubMed ID: 12000710
[TBL] [Abstract][Full Text] [Related]
38. Diffusion tensor imaging of the brain in patients with Alzheimer's disease and cerebrovascular lesions.
Chen SQ; Kang Z; Hu XQ; Hu B; Zou Y
J Zhejiang Univ Sci B; 2007 Apr; 8(4):242-7. PubMed ID: 17444598
[TBL] [Abstract][Full Text] [Related]
39. Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease.
Sachdeva AK; Chopra K
J Nutr Biochem; 2015 Jul; 26(7):736-44. PubMed ID: 25869595
[TBL] [Abstract][Full Text] [Related]
40. Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.
Thal DR; Del Tredici K; Ludolph AC; Hoozemans JJ; Rozemuller AJ; Braak H; Knippschild U
Acta Neuropathol; 2011 Nov; 122(5):577-89. PubMed ID: 21935637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
